Evidence map›Paper›PMID 39916770›Full record

Observational studyTransplant international : official journal of the European Society for Organ Transplantation2024

No Emergence of Colistin Resistance in the Respiratory Tract of Lung Transplant Patients Treated With Inhaled Colistin.

Nathalie Grall, Maksud Assadi, Marina Esposito-Farese, Brice Lortat-Jacob, Sébastien Tanaka, Enora Atchade, Jonathan Messika, Vincent Bunel, Hervé Mal, Pierre Mordant and 9 more

Abstract readObservational Study
PubMed Full text at PMC Publisher
In one paragraph

Observational study in Transplant international : official journal of the European Society for Organ Transplantation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Nathalie GrallUniversité Paris Cité, AP-HP, Hôpital Bichat Claude Bernard, Service de Bactériologie, Paris, France.
Maksud AssadiUniversité Paris Cité, AP-HP, Hôpital Bichat Claude Bernard, Département d'Anesthésie-Réanimation, Paris, France.
Marina Esposito-FareseUniversité Paris Cité, AP-HP, Hôpital Bichat, Département d'Epidémiologie et Recherche Clinique, Paris, France.
Brice Lortat-JacobUniversité Paris Cité, AP-HP, Hôpital Bichat Claude Bernard, Département d'Anesthésie-Réanimation, Paris, France.
Sébastien TanakaUniversité Paris Cité, AP-HP, Hôpital Bichat Claude Bernard, Département d'Anesthésie-Réanimation, Paris, France.
Enora AtchadeUniversité Paris Cité, AP-HP, Hôpital Bichat Claude Bernard, Département d'Anesthésie-Réanimation, Paris, France.
Jonathan MessikaUniversité Paris Cité, AP-HP, Hôpital Bichat Claude Bernard, Pneumologie B et Transplantation Pulmonaire, Paris, France.
Vincent BunelUniversité Paris Cité, AP-HP, Hôpital Bichat Claude Bernard, Pneumologie B et Transplantation Pulmonaire, Paris, France.
Hervé MalUniversité Paris Cité, AP-HP, Hôpital Bichat Claude Bernard, Pneumologie B et Transplantation Pulmonaire, Paris, France.
Pierre MordantINSERM UMR 1152 PHERE, Université Paris Cité, Paris, France.
Yves CastierINSERM UMR 1152 PHERE, Université Paris Cité, Paris, France.
Bastien GarnierUniversité Paris Cité, AP-HP, Hôpital Bichat Claude Bernard, Département d'Anesthésie-Réanimation, Paris, France.
Signara GueyeUniversité Paris Cité, AP-HP, Hôpital Bichat Claude Bernard, Service de Bactériologie, Paris, France.
Marie PetitjeanINSERM UMR 1137 IAME, Université Paris Cité, Paris, France.
Erick DenamurINSERM UMR 1137 IAME, Université Paris Cité, Paris, France.
Laurence Armand-LefevreUniversité Paris Cité, AP-HP, Hôpital Bichat Claude Bernard, Service de Bactériologie, Paris, France.
Charles BurdetUniversité Paris Cité, AP-HP, Hôpital Bichat, Département d'Epidémiologie et Recherche Clinique, Paris, France.
Philippe MontraversUniversité Paris Cité, AP-HP, Hôpital Bichat Claude Bernard, Département d'Anesthésie-Réanimation, Paris, France.
Alexy Tran-DinhUniversité Paris Cité, AP-HP, Hôpital Bichat Claude Bernard, Département d'Anesthésie-Réanimation, Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Secondary prophylaxis using inhaled colistin (IC) was implemented to prevent recurrences of Pseudomonas aeruginosa or extended-spectrum β-lactamase-producing Enterobacterales (ESBL-PE) pneumonia during the postoperative intensive care unit (ICU) stay after lung transplantation (LT). We evaluated the risk of emergence of colistin resistance in the respiratory tract during secondary IC prophylaxis. We conducted a prospective, single-centre, observational study of all adult patients who underwent LT between 1 July 2018 and 30 June 2019. IC was started and continued for at least 90 days for

Indexed as

Anti-Bacterial AgentsColistinDrug Resistance, BacterialLung TransplantationPneumonia, BacterialPseudomonas InfectionsAdministration, InhalationAdultAgedFemaleHumansMaleMiddle AgedProspective StudiesPseudomonas aeruginosaAnti-Bacterial AgentsColistincolistinlung transplantationpneumoniaprophylaxisresistance

Identifiers

PMID39916770
PMCPMC11799951

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.